doi: 10.1093/ntr/nts028.
Epub 2012 Mar 15.
The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation
Affiliations
- PMID: 22422928
- DOI: 10.1093/ntr/nts028
Item in Clipboard
The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation
Nicotine Tob Res.
2012 Dec.
No abstract available
Similar articles
-
Varenicline for smoking cessation.BMJ. 2012 Nov 8;345:e7547. doi: 10.1136/bmj.e7547. BMJ. 2012. PMID: 23138037 No abstract available.
-
In brief: Cardiovascular safety of varenicline (Chantix).Med Lett Drugs Ther. 2011 Aug 22;53(1371):65. Med Lett Drugs Ther. 2011. PMID: 21860367 No abstract available.
-
Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials.Am J Ther. 2013 May-Jun;20(3):235-46. doi: 10.1097/MJT.0b013e31828d455b. Am J Ther. 2013. PMID: 23615317
-
Safety of varenicline in patients with cardiovascular disease.J Pharm Pract. 2014 Feb;27(1):65-70. doi: 10.1177/0897190013504961. Epub 2013 Sep 30. J Pharm Pract. 2014. PMID: 24080536 Review.
-
Practical implementation of varenicline as an aid to smoking cessation in clinical practice.Pneumologia. 2009 Jul-Sep;58(3):167-74. Pneumologia. 2009. PMID: 19817313 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
